The Intravitreal IVT Injectable Market To Witness A Healthy Reverberation Betwee

Posted by Ashish on February 25th, 2021

Retinal diseases contributing heavily to the demand growth of intravitreal (IVT) injectables

Hereditary retinal diseases is the major cause of visual loss. Macular degeneration, Diabetic Retinopathy is the important and prominent cause of blindness.

According to Genentech Retinal disease report, around 11 million US population are affected with age-related macular degeneration, 7.7 million people are affected with diabetic retinopathy and around 1.1 million population are affected with retinal vein occlusions.

Strategizing The Moves For The Next Decade? See Through Sample Of Intravitreal IVT Injectable Market Report! https://www.persistencemarketresearch.co/samples/25906

Company Profiles

  • Regeneron Pharmaceuticals, Inc.
  • Bausch & Lomb
  • Novartis AG
  • Allergan
  • Alimera Sciences
  • ThromboGenics, Inc.
  • Bristol-Myers Squibb Company
  • Other

Like it? Share it!


Ashish

About the Author

Ashish
Joined: September 12th, 2019
Articles Posted: 582

More by this author